Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1993 Feb 15;90(4):1364-8.
doi: 10.1073/pnas.90.4.1364.

Evidence for functional interaction between elongation factor Tu and 16S ribosomal RNA

Affiliations

Evidence for functional interaction between elongation factor Tu and 16S ribosomal RNA

T Powers et al. Proc Natl Acad Sci U S A. .

Abstract

Translation of the genetic code requires the accurate selection of elongation factor (EF)-Tu.GTP.tRNA ternary complexes at the ribosomal acceptor site, or A site. Several independent lines of evidence have implicated the universally conserved 530 loop of 16S rRNA in this process; yet its precise role has not been identified. Using an allele-specific chemical probing strategy, we have examined the functional defect caused by a dominant lethal G-->A substitution at position 530. We find that mutant ribosomes are impaired in EF-Tu-dependent binding of aminoacyl-tRNA in vitro; in contrast, nonenzymatic binding of tRNA to the A and P sites is unaffected, indicating that the defect involves an EF-Tu-related function rather than tRNA-ribosome interactions per se. In vivo, the mutant ribosomes are found in polysomes at low levels and contain reduced amounts of A-site-bound tRNA, but normal levels of P-site tRNA, in agreement with the in vitro results; thus the dominant lethal phenotype of mutations at G530 can be explained by impaired interaction of mutant ribosomes with ternary complex. These results provide evidence for a newly defined function of 16S rRNA--namely, modulation of EF-Tu activity during translation.

PubMed Disclaimer

References

    1. Biochimie. 1987 Sep;69(9):911-23 - PubMed
    1. Nature. 1987 Jun 4-10;327(6121):389-94 - PubMed
    1. Nature. 1988 Jul 28;334(6180):362-4 - PubMed
    1. J Mol Biol. 1988 Jun 20;201(4):683-95 - PubMed
    1. EMBO J. 1988 Dec 1;7(12):3949-55 - PubMed

Publication types

Substances

LinkOut - more resources